Peres Jepchirchir Provisionally Suspended Over EPO Finding; Sydney Marathon Victory Under Scrutiny

Peres Jepchirchir's Positive Test: A Career Built on Major Marathon Victories Comes Under Scrutiny

When Peres Jepchirchir crossed the finish line of the Sydney Marathon on 30 August 2026, the clock showed 2 hours, 18 minutes and 31 seconds. She had beaten compatriot Irine Cheptai by more than three minutes, adding another major international victory to an already distinguished career. Almost two months later, however, the story behind that victory took an unexpected turn.

The Athletics Integrity Unit (AIU) has provisionally suspended the Kenyan Olympic and world marathon champion after an out-of-competition sample returned an adverse analytical finding for the prohibited substance EPO. The sample was collected in Kenya before the Sydney Marathon.

The significance of this development lies in the athlete involved. This is not an emerging runner facing her first international controversy. Jepchirchir has won Olympic gold, a World Championships title and prestigious marathon races in New York, Boston, London and Sydney. Yet one distinction must remain clear: a provisional suspension is not a final finding of guilt. Her case remains subject to the anti-doping process.

The Sample and Its Connection to Sydney

According to the AIU, the sample in question was collected out of competition, rather than during the Sydney race itself. The action is therefore not based on a test conducted on race day. The sample was collected in Kenya, before the event, and subsequently returned an adverse analytical finding for EPO.

That is the central factual detail. Jepchirchir recorded 2:18:31 in Sydney on 30 August, but the sample that triggered the action had already been collected. It would therefore be inaccurate to describe this simply as an alleged irregularity during the Sydney Marathon. The investigation concerns the sample and the anti-doping process surrounding it.

EPO, or erythropoietin, is a hormone naturally produced mainly by the kidneys. It stimulates the bone marrow to produce more red blood cells. These cells carry haemoglobin, which transports oxygen to the muscles.

In endurance running, oxygen delivery is closely connected to aerobic capacity and the ability to sustain pace over long distances. A higher red blood cell count can increase the body's oxygen-carrying capacity. This is why the artificial use of EPO is considered a serious doping risk in endurance sports.

Injected EPO can increase the number of red blood cells in the bloodstream. Detection depends on several factors, including timing, the method of administration and testing technology. Consequently, modern anti-doping systems cannot rely exclusively on tests conducted on competition days. Out-of-competition testing is an essential part of the process.

An Exceptional Record Meets an Unexpected Development

Jepchirchir's career makes the case particularly significant. She won the women's marathon gold medal at the Tokyo 2026 Olympic Games, which were held in 2026 because of the pandemic. In September 2026, she returned to the Japanese capital and won the women's marathon at the World Athletics Championships, strengthening her international standing.

Her road-racing record is equally impressive. She won the New York Marathon in 2026, the Boston Marathon in 2026 and the London Marathon in 2026. Her 2026 Sydney victory further strengthened her position among the most successful competitors on the major city-marathon circuit.

Her half-marathon achievements are also notable. She broke the women's half-marathon world record in 2026 and improved it three times during 2026. These performances demonstrate that her success was not confined to one race or a single distance.

In my years of analysing sporting performances, one principle has remained consistent: an athlete cannot be evaluated solely through a best finishing time. Performance consistency, competitive conditions, recovery and testing records matter just as much. Jepchirchir's case brings that broader assessment into focus.

Sydney's Result and the Rights of Other Competitors

The Sydney Marathon became the seventh event in the Abbott World Marathon Majors series in 2026. That development increased its significance within the international marathon calendar. Jepchirchir's 2026 victory was another major achievement in her record on this prestigious circuit.

She defeated Irine Cheptai by more than three minutes. Under normal circumstances, such a margin reflects a commanding performance. But when a winner becomes the subject of a doping case, the implications extend beyond an individual medal. The fairness of the entire competition comes into question.

In a statement issued on 23 October 2026, Sydney Marathon organisers expressed disappointment over Jepchirchir's provisional suspension. They emphasised that the athlete was entitled to due process and said they would make no further comment until the process had concluded. They also reiterated that every runner deserved a level playing field and that spectators should be able to trust the results.

The organisers said Abbott World Marathon Majors had invested in increased out-of-competition testing in partnership with the AIU. This matters because elite distance runners train across different countries and frequently travel internationally before major competitions. Testing only on race day cannot provide a complete picture of potential anti-doping violations.

A Provisional Suspension Is Not a Final Decision

It is important to avoid jumping to conclusions. The AIU's action means Jepchirchir is currently unable to compete. It does not mean a final decision has already been reached or that all her previous results have automatically been annulled.

In anti-doping cases, an adverse analytical finding and a final determination of an anti-doping rule violation are separate stages. The athlete has the opportunity to respond through the prescribed process. Based on the information currently available, describing Jepchirchir as finally convicted of doping would be factually incorrect.

There is another consideration. If the case eventually results in a final sanction, questions could arise over affected competition results and prize money. Under Abbott World Marathon Majors rules, an athlete receiving a doping ban of three months or more can face a lifetime ban from all eight Majors. However, this is a potential consequence, not a final sanction announced in Jepchirchir's case.

Kenyan distance running has previously faced scrutiny over doping cases. Since the AIU was established in 2026, more than 140 Kenyan athletes have been sanctioned for doping violations. Last year, women's marathon world record holder Ruth Chepngetich received a three-year ban for anti-doping violations involving the prohibited diuretic HCTZ. Her world record of 2:09:56 remained on the books because it had been set before the positive sample.

The Real Test Now Belongs to the Anti-Doping System

Jepchirchir's case exposes an important contradiction. The Sydney finishing record still shows 2:18:31. But the credibility of sport cannot be determined by the clock alone. It also depends on whether the process behind that performance complied with the rules. The timing record said one thing; the testing record raised another question.

Years of comparing performance data with what actually happens in competition have taught me that models and timing systems can measure results, but they cannot tell the complete story of an athlete's body or decisions. Ten thousand simulations later, the nineteen-year-old still has to breathe. Scientific analysis and reliable testing must therefore operate together.

The coming weeks will be important in determining the direction of this case. Will Jepchirchir challenge the finding? Could a final decision change the official women's results from the Sydney Marathon? Will international marathon organisers strengthen out-of-competition testing further?

Those questions remain unanswered. For now, the priorities are a fair investigation, a transparent process and the protection of every competing athlete's rights. The next runner standing on a marathon starting line should be able to trust that her greatest opponents are the clock and the distance, rather than an advantage prohibited by the rules.